PubRank

Vincent Levy

Author PubWeight™ 21.95‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Nonmalignant late effects after allogeneic stem cell transplantation. Blood 2003 2.95
2 Factors influencing inclusion of patients with malignancies in clinical trials. Cancer 2006 1.76
3 Deciphering leukemic B-cell chronic lymphoproliferative disorders. Leuk Lymphoma 2006 1.46
4 Lung abnormalities after dasatinib treatment for chronic myeloid leukemia: a case series. Am J Respir Crit Care Med 2007 1.42
5 Obesity leads to higher risk of sperm DNA damage in infertile patients. Asian J Androl 2013 1.34
6 Prognostic factors for leukemic induction failure in children with acute lymphoblastic leukemia and outcome after salvage therapy: the FRALLE 93 study. J Clin Oncol 2008 1.32
7 Binet's staging system and VH genes are independent but complementary prognostic indicators in chronic lymphocytic leukemia. J Clin Oncol 2003 1.08
8 Prospective evaluation of a polymerase chain reaction-ELISA targeted to Aspergillus fumigatus and Aspergillus flavus for the early diagnosis of invasive aspergillosis in patients with hematological malignancies. J Infect Dis 2006 1.04
9 Sequential chemotherapy regimens followed by high-dose therapy with stem cell transplantation in mantle cell lymphoma: an update of a prospective study. Haematologica 2004 1.01
10 Phase I study of bromohydrin pyrophosphate (BrHPP, IPH 1101), a Vgamma9Vdelta2 T lymphocyte agonist in patients with solid tumors. Cancer Immunol Immunother 2010 0.95
11 In vivo repopulation ability of genetically corrected bone marrow cells from Fanconi anemia patients. Proc Natl Acad Sci U S A 2006 0.94
12 Quality assessment of phase I dose-finding cancer trials: proposal of a checklist. Clin Trials 2008 0.88
13 Identification of prognostic factors in post-transplant lymphoproliferative disorders. Recent Results Cancer Res 2002 0.87
14 Old DAT and new data: positive direct antiglobulin test identifies a subgroup with poor outcome among chronic lymphocytic leukemia stage A patients. Am J Hematol 2014 0.86
15 Acadesine for patients with relapsed/refractory chronic lymphocytic leukemia (CLL): a multicenter phase I/II study. Cancer Chemother Pharmacol 2012 0.81
16 Deficient mismatch repair phenotype is a prognostic factor for colorectal cancer in elderly patients. Dig Liver Dis 2012 0.80
17 Recommendations of the SFH (French Society of Haematology) for the diagnosis, treatment and follow-up of hairy cell leukaemia. Ann Hematol 2014 0.78
18 Immunotherapy-based regimen in anti-MAG neuropathy: results in 45 patients. Haematologica 2013 0.77
19 Bendamustine and rituximab combination in the management of chronic lymphocytic leukemia-associated autoimmune hemolytic anemia: a multicentric retrospective study of the French CLL intergroup (GCFLLC/MW and GOELAMS). Am J Hematol 2015 0.77
20 Outcomes in critically ill chronic lymphocytic leukemia patients. Support Care Cancer 2013 0.76
21 [Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma]. Bull Cancer 2004 0.75
22 Methemoglobinemia and acute hemolysis after tetracaine lozenge use. J Crit Care 2006 0.75
23 [Identification of prognostic factors in post-transplantation lymphoproliferative disorders]. Bull Cancer 2004 0.75
24 Phase III study of chlorambucil versus fludarabine as initial therapy for Waldenstrom's macroglobulinemia and related disorders. Clin Lymphoma 2005 0.75
25 Interest in an original methodology to define the optimal dosage of interferon-alpha-2a in metastatic melanoma patients. Melanoma Res 2009 0.75
26 High-dose CD34+ cells are not clinically relevant in reducing cytopenia and blood component consumption following myeloablative therapy and peripheral blood progenitor cell transplantation as compared with standard dose. Transfusion 2002 0.75
27 Successful Heart Transplantation for Unreversible Endomyocardial Fibrosis Related to FIP1L1-PDGFRA Chronic Eosinophilic Leukemia. Transplantation 2015 0.75